APA (7th ed.) Citation

Szudy-Szczyrek, A., Chocholska, S., Bachanek-Mitura, O., Czabak, O., Mlak, R., Szczyrek, M., . . . Hus, M. (2021). Efficacy of ixazomib-lenalidomide-dexamethasone in high-molecular-risk relapsed/refractory multiple myeloma – case series and literature review. Institute of Rural Health.

Chicago Style (17th ed.) Citation

Szudy-Szczyrek, Aneta, Sylwia Chocholska, Oliwia Bachanek-Mitura, Olga Czabak, Radosław Mlak, Michał Szczyrek, Justyna Muzyka-Kasietczuk, and Marek Hus. Efficacy of Ixazomib-lenalidomide-dexamethasone in High-molecular-risk Relapsed/refractory Multiple Myeloma – Case Series and Literature Review. Institute of Rural Health, 2021.

MLA (9th ed.) Citation

Szudy-Szczyrek, Aneta, et al. Efficacy of Ixazomib-lenalidomide-dexamethasone in High-molecular-risk Relapsed/refractory Multiple Myeloma – Case Series and Literature Review. Institute of Rural Health, 2021.